Rocket Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer Ondrey Aaron unloaded Company’s shares for reported $4257.0 on Jul 03 ’25. In the deal valued at $2.88 per share,1,477 shares were sold. As a result of this transaction, Ondrey Aaron now holds 128,173 shares worth roughly $0.38 million.
Then, Ondrey Aaron bought 1,477 shares, generating $4,256 in total proceeds.
Before that, Militello John sold 357 shares. Rocket Pharmaceuticals Inc shares valued at $2,301 were divested by the insider at a price of $6.45 per share. As a result of the transaction, Militello John now holds 64,027 shares, worth roughly $0.19 million.
Evercore ISI downgraded its Rocket Pharmaceuticals Inc [RCKT] rating to an In-line from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in late May from “an Overweight” to “an Equal-weight”. Leerink Partners also remained covering RCKT and has decreased its forecast on May 28, 2025 with a “Market perform” recommendation from previously “an Outperform” rating. JP Morgan revised its rating on May 28, 2025. It rated RCKT as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of RCKT
On Tuesday, Rocket Pharmaceuticals Inc [NASDAQ:RCKT] saw its stock jump 5.34% to $2.96. Over the last five days, the stock has gained 20.82%. Rocket Pharmaceuticals Inc shares have fallen nearly -85.22% since the year began. Nevertheless, the stocks have fallen -76.45% over the past one year. While a 52-week high of $26.98 was reached on 01/02/25, a 52-week low of $2.19 was recorded on 05/27/25.
Levels Of Support And Resistance For RCKT Stock
The 24-hour chart illustrates a support level at 2.84, which if violated will result in even more drops to 2.73. On the upside, there is a resistance level at 3.02. A further resistance level may holdings at 3.09.
How much short interest is there in Rocket Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rocket Pharmaceuticals Inc stocks on 2025-06-13, growing by 98360.0 shares to a total of 14.04 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 13.94 million shares. There was a rise of 0.7%, which implies that there is a positive sentiment for the stock.
